Global Anti-aging Therapeutics Market 2022

Report ID : 1249 | Published : 2022-06-08 | Pages: 157 | Format: PDF/EXCEL

The global Anti-aging Therapeutics market size was accounted at USD 518.86 Mn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 16.53% from 2022 to 2030. Anti-aging treatment combines cutting-edge research and medical technology to identify, prevent, cure, and reverse age-related dysfunctions, illnesses, and diseases as early as possible. As a result, anti-aging preventive medicine and healthcare are critical components in assisting senior people in living healthy and active lives. The progress of technology offers the detection, prevention, and treatment of age-related diseases and the promotion of research into strategies to slow and optimize the human ageing process. Researchers have made considerable progress in understanding stem cell ageing and the molecular processes behind this process during the last decade. Few studies have also validated the extrinsic factors, while transplantation experiments have found the intrinsic components that induce an age-dependent reduction in stem cell quantity and function.

The rise in consumer demand for anti-aging therapeutics, combined with an increase in lifestyle standards and income among the world's population, is the primary factor driving the growth of the anti-aging therapeutics market over the forecast period. Furthermore, technological advancements and increased investment in research and development activities by major players for the development of highly safe and efficient treatment solutions are expected to propel the anti-aging therapeutics market globally.

Market Segmentation:

The Anti-aging Therapeutics market is segmented on the basis of type of molecule, type of aging and mechanism of action. Based on type of molecule, the market is segmented as Biologics and Small Molecules. The type of aging segment includes Cellular Aging, Immune Aging, Metabolic Aging and Others. By mechanism of action, the market is segmented into Senolytic, Cell Regeneration, mTOR inhibitor/Modulator, AMP-kinase/AMP Activator, Mitochondria Inhibitor/Modulator and Others.

Based on type of molecule, the small molecule segment is accounted as a major contributor in the Anti-aging Therapeutics market

The small molecule segment is accounted as a major contributor in the Anti-aging Therapeutics market. Small molecules can delay multiple aging diseases and increase lifespan. In theory, such molecules could simultaneously prevent dozens of diseases, potentially extending healthy years of life.

Cellular aging segment witnessed growth at a rapid rate

Cellular aging is generally defined as a progressive decrease in resistance to stress and other cellular damages, resulting in a gradual loss of cellular functions and, eventually, cell demise. Cells age as they divide, multiply, and perform their assigned functions. And as they age, the body has remarkable mechanisms in place to care for aging cells and replenish them with new ones.

In the region, the North America Anti-aging Therapeutics market holds a significant revenue share.

The anti-aging therapeutics market in North America is expected to grow significantly due to the availability of well-established infrastructure, key market players, and the region's increasing average life expectancy and median age. However, the rising popularity of anti-aging therapeutics and favorable reimbursement policies are expected to boost regional growth during the forecast period. Furthermore, companies in the region are working hard to improve their market position through R&D and new product launches. Moreover, Asia Pacific is the most populous region on the planet, with a sizable market for anti-aging therapeutics. The development of infrastructure and facilities to advance stem cell research in both developed and emerging nations is driving market expansion in this region.

Competitive Landscape

Some of the primary key players in the Anti-aging Therapeutics market are AgelessRx, ANOVA Institute for Regenerative Medicine, Betterhumans, BioAge Labs, BIOPHYTIS BSA, bioXcellerator, Cambrian Biopharma, CytoMed Therapeutics, Gero.ai, Rejuvenate Bio, Rejenevie Therapeutics, UT Health San Antonio, MyMD Pharmaceuticals, Intervene Immune, Inc., CohBar, Inc., Alkahest, Athersys Inc, BHB Therapeutics, Biosplice, Cyclo Therapeutics, Denali Therapeutics, Elysium Health, Genome Protection, GenSight Biologics, Intervene Immune, Khondrian, Longeveron, LyGenesis, Mesoblast, Minovia Therapeutics, Mitobridge, Navitor Pharmaceuticals, NeuroTrack, Nuchido, NuSirt, OneSkin Technologies, PharmatrophiX, Proteostasis Therapeutics, Retrotope, Stealth Biotherapeutics, TA Sciences, Unity BiotechnologyYounger Phenotype, and Other Prominent Players.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Anti-aging Therapeutics Market Snapshot

Chapter 4. Global Anti-aging Therapeutics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Molecule, Estimates & Trend Analysis

5.1. By Molecules, & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Molecules:

5.2.1. Biologics

5.2.2. Small Molecules

Chapter 6. Market Segmentation 2: By Aging Types Estimates & Trend Analysis

6.1. By Aging Types & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Aging Types:

6.2.1. Cellular Aging

6.2.2. Immune Aging

6.2.3. Metabolic Aging

6.2.4. Other Aging Types

Chapter 7. Market Segmentation 3: By Mechanism of Action Estimates & Trend Analysis

7.1. By Mechanism of Action & Market Share, 2020& 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Mechanism of Action:

7.2.1. Senolytic

7.2.2. Cell Regeneration

7.2.3. mTOR inhibitor/Modulator

7.2.4. AMP-kinase/AMP Activator

7.2.5. Mitochondria Inhibitor/Modulator

7.2.6. other Mechanism of Action

Chapter 8. Anti-aging Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Molecules, 2019-2030

8.1.2. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Aging Types, 2019-2030

8.1.3. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Mechanism of Action, 2019-2030

8.1.4. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts by country, 2019-2030

8.2. Europe

8.2.1. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2019-2030

8.2.2. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2019-2030

8.2.3. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2019-2030

8.2.4. Europe Anti-aging Therapeutics Market revenue (US$ Million) by country, 2019-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2019-2030

8.3.2. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2019-2030

8.3.3. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2019-2030

8.3.4. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) by country, 2019-2030

8.4. Latin America

8.4.1. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2019-2030

8.4.2. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2019-2030

8.4.3. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2019-2030

8.4.4. Latin America Anti-aging Therapeutics Market revenue (US$ Million) by country, 2019-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2019-2030

8.5.2. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2019-2030

8.5.3. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2019-2030

8.5.4. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) by country, 2019-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

 9.2.1. AgelessRx

9.2.2. ANOVA Institute for Regenerative Medicine

9.2.3. Betterhumans

9.2.4. BioAge Labs

9.2.5. BIOPHYTIS BSA

9.2.6. bioXcellerator

9.2.7. Cambrian Biopharma

9.2.8. CytoMed Therapeutics

9.2.9. Gero.ai

9.2.10. Rejuvenate Bio

9.2.11. Rejenevie Therapeutics

9.2.12. UT Health San Antonio

9.2.13. MyMD Pharmaceuticals

9.2.14. Intervene Immune, Inc.

9.2.15. CohBar, Inc.

9.2.16. Alkahest

9.2.17. Athersys Inc

9.2.18. BHB Therapeutics

9.2.19. Biosplice

9.2.20. Cyclo Therapeutics

9.2.21. Denali Therapeutics

9.2.22. Elysium Health

9.2.23. Genome Protection

9.2.24. GenSight Biologics

9.2.25. Intervene Immune

9.2.26. Khondrian

9.2.27. Longeveron

9.2.28. LyGenesis

9.2.29. Mesoblast

9.2.30. Minovia Therapeutics

9.2.31. Mitobridge

9.2.32. Navitor Pharmaceuticals

9.2.33. NeuroTrack

9.2.34. Nuchido

9.2.35. NuSirt

9.2.36. OneSkin Technologies

9.2.37. PharmatrophiX

9.2.38. Proteostasis Therapeutics

9.2.39. Retrotope

9.2.40. Stealth Biotherapeutics

9.2.41. TA Sciences

9.2.42. Unity Biotechnology

9.2.43. Younger Phenotype

9.2.44. Other Prominent Players

 

Segmentation of Anti-aging Therapeutics Market-

By Type of Molecule

  • Biologics
  • Small Molecules

By Type of Aging

  • Cellular Aging
  • Immune Aging
  • Metabolic Aging
  • Others

By Mechanism of Action

  • Senolytic
  • Cell Regeneration
  • mTOR inhibitor/Modulator
  • AMP-kinase/AMP Activator
  • Mitochondria Inhibitor/Modulator
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Need Complete Report ?
Our Clients